Home  |  Blog  |  Press Statement  |  CCPA Statement on Prescription Drug Pricing Reform

CCPA Statement on Prescription Drug Pricing Reform

Congress has a unique opportunity this year to pass meaningful, patient focused reforms that will help ensure people living with chronic conditions can access the medications they need to lead and healthy lives in its reconciliation package. Unfortunately, the latest proposal on prescription drugs not only includes policies that could result in more restricted access to treatments, or fewer treatments being developed, but also strips away protections that were in previous versions of the package. CCPA remains dedicated to working with Congress on legislation that puts patients first and addresses these critical areas in the reconciliation package. We urge Congress to reject provisions that undermine non-interference or implement price controls that may ultimately do more harm to patients than good. Instead, they should implement reasonable caps on all patient costs including premiums, and ensure an environment that encourages innovation and new treatments.